TransCode Therapeutics (RNAZ) Stock Price & Financial Analysis
TransCode Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About TransCode Therapeutics
What is the current stock price for RNAZ?
As of the latest trading session, RNAZ stock trades at $6.18. The 52-week range is $6.08–$20.99, with a day range of $6.01–$6.50.
What is the P/E ratio for RNAZ?
The P/E ratio (Price-to-Earnings) for RNAZ is shown in the Key Statistics section. This valuation metric helps compare TransCode Therapeutics, Inc. to industry peers.
Does RNAZ pay dividends?
TransCode Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RNAZ?
Analyst ratings and recommendations for RNAZ are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RNAZ?
TransCode Therapeutics's market capitalization is $4.3M, classifying it as a micro-cap company. TransCode Therapeutics operates in the Healthcare sector within the Biotechnology industry.